Contents
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Volume 5 - Number 6
Clinical View on the Need to Develop New Anti-Diabetic Drugs
, 5(6): 469 - 474L. Laviola, A. Cignarelli and F. Giorgino
DOI: 10.2174/156801305774962213
GLP-1, Incretin Mimetics and DPP 4 Inhibitors: New Ways in the Treatment of Type 2 Diabetes
, 5(6): 485 - 497Juris J. Meier and Michael A. Nauck
DOI: 10.2174/156801305774962150
Glucose Transport Regulators
, 5(6): 519 - 527M. Ben-Yakir, A. Gruzman, E. Alpert and S. Sasson
DOI: 10.2174/156801305774962259
Serine Kinases as New Drug Targets for the Treatment of Type 2 Diabetes
, 5(6): 529 - 536Cristina M. Rondinone
DOI: 10.2174/156801305774962196
Graft Versus Host Disease
, 5(6): 539 - 545J. L.M. Ferrara and S. Mineishi
DOI: 10.2174/156801305774962222
In Vitro and In Vivo Sirolimus for Modulation of Allogeneic Hematopoietic Stem Cell Transplantation
, 5(6): 555 - 564Daniel H. Fowler and Ronald E. Gress
DOI: 10.2174/156801305774962132
Protective Growth Factors for Graft-Versus-Host Disease
, 5(6): 565 - 573Tsuyoshi Iwasaki
DOI: 10.2174/156801305774962141
The Parent-into-F1 Model of Graft-vs-Host Disease as a Model of In Vivo T Cell Function and Immunomodulation
, 5(6): 575 - 583R. A. Pulaiev, I. A. Puliaeva, A. E. Ryan and C. S. Via
DOI: 10.2174/156801305774962204
Webmaster Contact: info@benthamscience.net